The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual Quarterly Steering Committee Meeting on Tuesday, March 11, 2025 from 1:00 – 5:00 p.m. ET. 

Successful implementation and sustainment of interventions is heavily influence by context. Yet the complexity and dynamic nature of context make it challenging to connect and translate findings across implementation efforts, limiting potential replicability and utility. The Inventory of Factors Affecting Successful Implementation and Sustainment (IFASIS) was developed to be a pragmatic, quantitative, organizational-level assessment of contextual factors. The intention is to characterize context with a measure that may enhance replication and reproducibility of findings beyond single implementation case studies. In this talk, the development and validation of the IFASIS will be presented, as well as examples of its practical utility. Speaker: Helene Chokron Garneau, PhD, MPH (Senior Research Scientist at Stanford University School of Medicine and co-Director of the Center for Dissemination and Implementation At Stanford (C-DIAS). To join the session, contact Elena Rosenberg-Carlson at rosenbee@stanford.edu

Michelle “Lani” Shiota, Ph.D. Professor, Department of Psychology Director, Substance use and Addiction Translational Research Network (SATRN) Arizona State University Dr. Michelle “Lani” Shiota is a Professor of Psychology at ASU conducting research on positive emotions, emotion regulation, and emotion-related mechanisms of health behavior. As Director of SATRN@ASU she guides a network of academic researchers and community partners in promoting community-engaged and interdisciplinary addiction science as well as evidence-based practice. A former junior high science teacher and teen dance instructor, Dr. Shiota also brings a unique perspective on issues related to youth substance use. Dr. Shiota’s presentation will delve into implications of basic emotion science for innovative, mechanistic research on substance use prevention, treatment, and harm reduction. Informed by psychology, neuroscience, and addiction science, the presentation will highlight distinct research questions revealed through this lens, as well as opportunities for intervention.  

The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.  

The Annual CPDD meeting for 2025 will be held June 14-18, 2026 in New Orleans, LA.